Cutting-edge medical treatments like gene therapy and cancer diagnostics require access to many separately patented genes, each owned by a small biotech startup that demands a price reflecting potential profits from the whole therapy, creating a holdup problem where assembling all the patents becomes prohibitively costly.
causalpending
Speaker
Michael HellerEvidence Quote
“unless you can assemble get agreement from every single patent owner in the room the tool or the therapy doesn't work”
Created: 6/16/2026, 2:51:25 PM
Your notes
Loading notes...